Phase 1 biotech developing therapies for neurodegeneration.
Industry: Health Care
First Day Return: -5.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/07/2019 |
Offer Price | $19.00 |
Price Range $18.00 - $20.00 | |
Offer Shares (mm) | 9.3 |
Deal Size ($mm) | $176 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/06/2019 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $176 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | South San Francisco, CA, United States |
Founded | 2013 |
Employees at IPO | 78 |
Website www.alector.com |